Skip to main content
. 2019 Mar 1;24(2):357–380. doi: 10.1111/bjhp.12357

Table 1.

Participant characteristics

Participant number Gender Age category (years) Types of nebulized treatments taken (D, A, Ha) Mean adherence categoryb IMD deprivation quintilec
1 M 19–25 D VL 4
2 M 16–18 D VL 3
3 F 31+ D, A VL 3
4 F 31+ D, A, H VL 4
5 F 26–30 D, A VL 5
6 F 16–18 D, A L 4
7 M 19–25 D, A L 5
8 M 19–25 D, A L 4
9 M 26–30 D, A L 4
10 M 26–30 D, A, H L 2
11 M 31+ D, A, H M 2
12 M 19–25 D, A M 3
13 M 31+ D, A, H M 4
14 M 16–18 D, A, H M 3
15 M 16–18 D, A H 2
16 F 31+ D, H H 3
17 M 31+ D, A H 2
18 M 19–25 D, A, H H 4
a

D = dornase alpha (mucolytic), A = antibiotic: either a single antibiotic, or two antibiotics taken in alternate months, H = hypertonic saline (mucolytic).

b

Where very low adherers (VL) = 0%–25% mean adherence, low adherers (L) = 25.1%–50% mean adherence, moderate adherers (M) = 50.1%–75% mean adherence, and high adherers (H) = 75.1 + % mean adherence.

c

IMD deprivation quintiles: 1 ≤ 8.49 (Least deprived), 2: 8.5–13.79, 3: 13.8–21.35, 4: 21.36–34.17, 5: ≥34.18 (Most deprived).